91 related articles for article (PubMed ID: 8609726)
1. Correlations between karyotype and cytologic findings in multiple myeloma.
Weh HJ; Bartl R; Seeger D; Selbach J; Kuse R; Hossfeld DK
Leukemia; 1995 Dec; 9(12):2119-22. PubMed ID: 8609726
[TBL] [Abstract][Full Text] [Related]
2. Karyotype in multiple myeloma and plasma cell leukaemia.
Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
[TBL] [Abstract][Full Text] [Related]
3. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
[TBL] [Abstract][Full Text] [Related]
4. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
[TBL] [Abstract][Full Text] [Related]
5. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
[TBL] [Abstract][Full Text] [Related]
7. t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.
Garand R; Avet-Loiseau H; Accard F; Moreau P; Harousseau JL; Bataille R
Leukemia; 2003 Oct; 17(10):2032-5. PubMed ID: 14513054
[TBL] [Abstract][Full Text] [Related]
8. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
10. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.
Baur A; Bartl R; Pellengahr C; Baltin V; Reiser M
Cancer; 2004 Dec; 101(11):2599-604. PubMed ID: 15503306
[TBL] [Abstract][Full Text] [Related]
11. [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].
Moro MJ; Portero JA; Gascón A; Hernández JM; Ortega F; Jiménez R; Guerras L; Martínez M; Casanova F; Sanz MA
Sangre (Barc); 1992 Jun; 37(3):175-9. PubMed ID: 1440094
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow plasma cell infiltration in multiple myeloma.
de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
[No Abstract] [Full Text] [Related]
13. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
[TBL] [Abstract][Full Text] [Related]
16. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.
Athanasiou E; Kaloutsi V; Kotoula V; Hytiroglou P; Kostopoulos I; Zervas C; Kalogiannidis P; Fassas A; Christakis JI; Papadimitriou CS
Am J Clin Pathol; 2001 Oct; 116(4):535-42. PubMed ID: 11601138
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of bone marrow angiogenesis in multiple myeloma.
Rajkumar SV; Leong T; Roche PC; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
[TBL] [Abstract][Full Text] [Related]
19. Digital image analysis of mean AgNOR area objectively discriminates between reactive plasmacytosis and multiple myeloma in cytologic smears from bone marrow aspirates.
Gunia S; Mai PA; Koch S
Pathobiology; 2008; 75(5):306-11. PubMed ID: 18931533
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
Abdalla S; May PC; Garimberti E; Naresh KN
Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
